A detailed history of Bessemer Group Inc transactions in Danaher Corp stock. As of the latest transaction made, Bessemer Group Inc holds 2,050,302 shares of DHR stock, worth $478 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
2,050,302
Previous 1,725,893 18.8%
Holding current value
$478 Million
Previous $431 Million 32.19%
% of portfolio
0.94%
Previous 0.76%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$239.25 - $280.76 $77.6 Million - $91.1 Million
324,409 Added 18.8%
2,050,302 $570 Million
Q2 2024

Aug 13, 2024

BUY
$235.51 - $267.98 $54.9 Million - $62.5 Million
233,147 Added 15.62%
1,725,893 $431 Million
Q1 2024

May 13, 2024

SELL
$224.58 - $256.19 $62.2 Million - $71 Million
-277,010 Reduced 15.65%
1,492,746 $373 Million
Q4 2023

Feb 09, 2024

SELL
$185.1 - $233.13 $9.45 Million - $11.9 Million
-51,061 Reduced 2.8%
1,769,756 $409 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $6.57 Million - $7.48 Million
28,167 Added 1.57%
1,820,817 $452 Million
Q2 2023

Aug 10, 2023

BUY
$224.99 - $256.14 $67.4 Million - $76.8 Million
299,728 Added 20.08%
1,792,650 $430 Million
Q1 2023

May 10, 2023

SELL
$239.75 - $277.0 $25.2 Million - $29.1 Million
-104,944 Reduced 6.57%
1,492,922 $376 Million
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $73.5 Million - $85.9 Million
-304,242 Reduced 15.99%
1,597,866 $424 Million
Q3 2022

Nov 09, 2022

SELL
$247.06 - $1507.4 $2.47 Million - $15.1 Million
-10,005 Reduced 0.52%
1,902,108 $491 Million
Q2 2022

Aug 10, 2022

SELL
$237.11 - $299.66 $227,625 - $287,673
-960 Reduced 0.05%
1,912,113 $485 Million
Q1 2022

May 12, 2022

BUY
$257.27 - $315.76 $8.99 Million - $11 Million
34,949 Added 1.86%
1,913,073 $561 Million
Q4 2021

Jan 27, 2022

BUY
$292.08 - $329.01 $8.7 Million - $9.8 Million
29,778 Added 1.61%
1,878,124 $618 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $4.66 Million - $5.7 Million
17,137 Added 0.94%
1,848,346 $563 Million
Q2 2021

Aug 06, 2021

BUY
$225.08 - $271.69 $6.82 Million - $8.23 Million
30,297 Added 1.68%
1,831,209 $491 Million
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $57.3 Million - $66.3 Million
-269,760 Reduced 13.03%
1,800,912 $405 Million
Q4 2020

Feb 09, 2021

SELL
$212.5 - $245.46 $137 Million - $159 Million
-647,054 Reduced 23.81%
2,070,672 $460 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $3.82 Million - $4.65 Million
-21,589 Reduced 0.79%
2,717,726 $585 Million
Q2 2020

Aug 05, 2020

BUY
$128.7 - $176.83 $7.07 Million - $9.71 Million
54,917 Added 2.05%
2,739,315 $484 Million
Q1 2020

Apr 30, 2020

SELL
$121.39 - $169.05 $8.84 Million - $12.3 Million
-72,798 Reduced 2.64%
2,684,398 $372 Million
Q4 2019

Feb 04, 2020

SELL
$133.47 - $153.48 $4.31 Million - $4.95 Million
-32,273 Reduced 1.16%
2,757,196 $423 Million
Q3 2019

Nov 07, 2019

BUY
$135.4 - $146.47 $197,954 - $214,139
1,462 Added 0.05%
2,789,469 $403 Million
Q2 2019

Jul 19, 2019

BUY
$124.88 - $143.73 $26.3 Million - $30.3 Million
210,506 Added 8.17%
2,788,007 $398 Million
Q1 2019

May 13, 2019

SELL
$97.62 - $132.29 $12.5 Million - $17 Million
-128,475 Reduced 4.75%
2,577,501 $340 Million
Q4 2018

Feb 12, 2019

SELL
$94.85 - $109.54 $37.4 Million - $43.2 Million
-394,696 Reduced 12.73%
2,705,976 $279 Million
Q3 2018

Nov 06, 2018

SELL
$98.13 - $108.9 $43.7 Million - $48.5 Million
-445,114 Reduced 12.55%
3,100,672 $337 Million
Q2 2018

Jul 25, 2018

BUY
$96.1 - $103.24 $684,520 - $735,378
7,123 Added 0.2%
3,545,786 $350 Million
Q1 2018

May 10, 2018

BUY
$92.16 - $103.8 $3.56 Million - $4.01 Million
38,680 Added 1.11%
3,538,663 $346 Million
Q4 2017

Jan 30, 2018

BUY
$85.26 - $94.62 $93,018 - $103,230
1,091 Added 0.03%
3,499,983 $325 Million
Q3 2017

Nov 03, 2017

BUY
$79.29 - $88.45 $277 Million - $309 Million
3,498,892
3,498,892 $300 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.